LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
24,855,468
Share change
-2,434,015
Total reported value
$218,907,700
Put/Call ratio
99%
Price per share
$8.80
Number of holders
73
Value change
-$22,107,862
Number of buys
32
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q3 2019

As of 30 Sep 2019, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,855,468 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, BlackRock Inc., VHCP Management III, LLC, Sectoral Asset Management Inc, VANGUARD GROUP INC, MORGAN STANLEY, and BOXER CAPITAL, LLC. This page lists 73 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.